Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

Jade Pharmaceuticals/RXPC

http://www.jaderx.com/PlatformApps/JadeRX/c1/index.html


Multiple Diagnostics Ventures

Algorithm Development & Automation of therapeutic Cortisol modalities output in response to direct readings of diagnostic instrumentation of patient salivary hormonal ELISA plates.
Analytics workflow novel development for the matrix readings of but not limited to THC, CBD, CBN potency, sterility & composition over time utilizing USP governance.

Gold Seeker Friday, 10/31/14 04:18:08 AM
Re: dcspka post# 23120
Post # of 25905
DC, I thought you claimed the Aussies were just place holders.

Your post claims otherwise.


"This explains why Dennis Charter took on the job as CEO of RXPC without apparent compensation. He will instead be given the opportunity to set up a Pharma company which has a Long Reach into early preventative Cancer Testing.

Charter will have his Saliva Test, licensing agreements with William Gartner on LC Sentinal/New Onko-Sure, and access to the other patents Gartner took with him when he left the CEO helm of Provista.

Could make for an exciting venture- right up Charter's alley."